Thomas Bieber

Research interests

Publications

• European guideline (EuroGuiDerm) on atopic eczema: part I – systemic therapy

  Journal of the European Academy of Dermatology and Venereology · 2022 · https://doi.org/10.1111/jdv.18345

• Atopic dermatitis: an expanding therapeutic pipeline for a complex disease

  Nature Reviews Drug Discovery · 2021 · 10.1038/s41573-021-00266-6

• Abrocitinib versus Placebo or Dupilumab for Atopic Dermatitis

  New England Journal of Medicine · 2021 · 10.1056/nejmoa2019380

• Safety and efficacy of upadacitinib in combination with topical corticosteroids in adolescents and adults with moderate-to-severe atopic dermatitis (AD Up): results from a randomised, double-blind, placebo-controlled, phase 3 trial

  The Lancet · 2021 · 10.1016/s0140-6736(21)00589-4

• Trial of Nemolizumab in Moderate-to-Severe Prurigo Nodularis

  New England Journal of Medicine · 2020 · https://doi.org/10.1056/nejmoa1908316

• Baricitinib in patients with moderate‐to‐severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy phase III trials

  British Journal of Dermatology · 2020 · 10.1111/bjd.18898

• Efficacy and safety of abrocitinib in adults and adolescents with moderate-to-severe atopic dermatitis (JADE MONO-1): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial

  The Lancet · 2020 · 10.1016/s0140-6736(20)30732-7

• Interleukin‐13: Targeting an underestimated cytokine in atopic dermatitis

  Allergy · 2019 · 10.1111/all.13954

• Atopic dermatitis

  Nature Reviews Disease Primers · 2018 · https://doi.org/10.1038/s41572-018-0001-z

• Efficacy and safety of lebrikizumab (an anti-IL-13 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical corticosteroids: A randomized, placebo-controlled phase II trial (TREBLE)

  Journal of the American Academy of Dermatology · 2018 · https://doi.org/10.1016/j.jaad.2018.01.017

• Consensus‐based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I

  Journal of the European Academy of Dermatology and Venereology · 2018 · https://doi.org/10.1111/jdv.14891

• Consensus‐based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part II

  Journal of the European Academy of Dermatology and Venereology · 2018 · https://doi.org/10.1111/jdv.14888

• Cellular and molecular immunologic mechanisms in patients with atopic dermatitis

  Journal of Allergy and Clinical Immunology · 2016 · 10.1016/j.jaci.2016.06.010

• Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis

  New England Journal of Medicine · 2016 · https://doi.org/10.1056/nejmoa1610020

• Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging phase 2b trial

  The Lancet · 2015 · https://doi.org/10.1016/s0140-6736(15)00388-8

• Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis

  New England Journal of Medicine · 2014 · https://doi.org/10.1056/nejmoa1314768

• Guidelines for treatment of atopic eczema (atopic dermatitis) Part II

  Journal of the European Academy of Dermatology and Venereology · 2012 · https://doi.org/10.1111/j.1468-3083.2012.04636.x

• Guidelines for treatment of atopic eczema (atopic dermatitis) Part I

  Journal of the European Academy of Dermatology and Venereology · 2012 · https://doi.org/10.1111/j.1468-3083.2012.04635.x

• Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyroperoxidase

  Journal of Allergy and Clinical Immunology · 2011 · https://doi.org/10.1016/j.jaci.2011.04.038

• Atopic Dermatitis

  New England Journal of Medicine · 2008 · https://doi.org/10.1056/nejmra074081

• Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report

  Allergy · 2006 · https://doi.org/10.1111/j.1398-9995.2006.01153.x

• Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report

  Journal of Allergy and Clinical Immunology · 2006 · https://doi.org/10.1016/j.jaci.2006.03.045

• Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003

  Journal of Allergy and Clinical Immunology · 2004 · https://doi.org/10.1016/j.jaci.2003.12.591

• Fotemustine Compared With Dacarbazine in Patients With Disseminated Malignant Melanoma: A Phase III Study

  Journal of Clinical Oncology · 2004 · 10.1200/jco.2004.04.165

• Allergic and nonallergic forms of atopic diseases

  Journal of Allergy and Clinical Immunology · 2003 · 10.1067/mai.2003.1595

• A Short-Term Trial of Tacrolimus Ointment for Atopic Dermatitis

  New England Journal of Medicine · 1997 · https://doi.org/10.1056/nejm199709183371203

• Immunomorphological and Ultrastructural Characterization of Langerhans Cells and a Novel, Inflammatory Dendritic Epidermal Cell (IDEC) Population in Lesional Skin of Atopic Eczema

  Journal of Investigative Dermatology · 1996 · 10.1111/1523-1747.ep12343596

Current projects

No projects listed.